Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?

Huntington’s disease (HD) is an inherited neurodegenerative disorder characterized by neuronal loss and tissue atrophy mainly in the striatum and cortex. In the early stages of the disease, impairment of neuronal function, synaptic dysfunction and white matter loss precedes neuronal death itself. Re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Luisana Villegas, Anne Nørremølle, Kristine Freude, Frederik Vilhardt
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/a2319712680544fca900d3b65930a9f1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a2319712680544fca900d3b65930a9f1
record_format dspace
spelling oai:doaj.org-article:a2319712680544fca900d3b65930a9f12021-11-05T08:17:12ZNicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?1663-436510.3389/fnagi.2021.736734https://doaj.org/article/a2319712680544fca900d3b65930a9f12021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnagi.2021.736734/fullhttps://doaj.org/toc/1663-4365Huntington’s disease (HD) is an inherited neurodegenerative disorder characterized by neuronal loss and tissue atrophy mainly in the striatum and cortex. In the early stages of the disease, impairment of neuronal function, synaptic dysfunction and white matter loss precedes neuronal death itself. Relative to other neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease and Amyotrophic Lateral Sclerosis, where the effects of either microglia or NADPH oxidases (NOXs) are recognized as important contributors to disease pathogenesis and progression, there is a pronounced lack of information in HD. This information void contrasts with evidence from human HD patients where blood monocytes and microglia are activated well before HD clinical symptoms (PET scans), and the clear signs of oxidative stress and inflammation in post mortem HD brain. Habitually, NOX activity and oxidative stress in the central nervous system (CNS) are equated with microglia, but research of the last two decades has carved out important roles for NOX enzyme function in neurons. Here, we will convey recent information about the function of NOX enzymes in neurons, and contemplate on putative roles of neuronal NOX in HD. We will focus on NOX-produced reactive oxygen species (ROS) as redox signaling molecules in/among neurons, and the specific roles of NOXs in important processes such as neurogenesis and lineage specification, neurite outgrowth and growth cone dynamics, and synaptic plasticity where NMDAR-dependent signaling, and long-term depression/potentiation are redox-regulated phenomena. HD animal models and induced pluripotent stem cell (iPSC) studies have made it clear that the very same physiological processes are also affected in HD, and we will speculate on possible roles for NOX in the pathogenesis and development of disease. Finally, we also take into account the limited information on microglia in HD and relate this to any contribution of NOX enzymes.Luisana VillegasAnne NørremølleKristine FreudeFrederik VilhardtFrontiers Media S.A.articleHuntington’s (disease)NADPH (nicotinamide adenine dinucleotide phosphate) oxidaseneuronHuntingtin (HTT)NMDAR (NMDA receptor)LTP (long term potentiation)Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Aging Neuroscience, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Huntington’s (disease)
NADPH (nicotinamide adenine dinucleotide phosphate) oxidase
neuron
Huntingtin (HTT)
NMDAR (NMDA receptor)
LTP (long term potentiation)
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Huntington’s (disease)
NADPH (nicotinamide adenine dinucleotide phosphate) oxidase
neuron
Huntingtin (HTT)
NMDAR (NMDA receptor)
LTP (long term potentiation)
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Luisana Villegas
Anne Nørremølle
Kristine Freude
Frederik Vilhardt
Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
description Huntington’s disease (HD) is an inherited neurodegenerative disorder characterized by neuronal loss and tissue atrophy mainly in the striatum and cortex. In the early stages of the disease, impairment of neuronal function, synaptic dysfunction and white matter loss precedes neuronal death itself. Relative to other neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease and Amyotrophic Lateral Sclerosis, where the effects of either microglia or NADPH oxidases (NOXs) are recognized as important contributors to disease pathogenesis and progression, there is a pronounced lack of information in HD. This information void contrasts with evidence from human HD patients where blood monocytes and microglia are activated well before HD clinical symptoms (PET scans), and the clear signs of oxidative stress and inflammation in post mortem HD brain. Habitually, NOX activity and oxidative stress in the central nervous system (CNS) are equated with microglia, but research of the last two decades has carved out important roles for NOX enzyme function in neurons. Here, we will convey recent information about the function of NOX enzymes in neurons, and contemplate on putative roles of neuronal NOX in HD. We will focus on NOX-produced reactive oxygen species (ROS) as redox signaling molecules in/among neurons, and the specific roles of NOXs in important processes such as neurogenesis and lineage specification, neurite outgrowth and growth cone dynamics, and synaptic plasticity where NMDAR-dependent signaling, and long-term depression/potentiation are redox-regulated phenomena. HD animal models and induced pluripotent stem cell (iPSC) studies have made it clear that the very same physiological processes are also affected in HD, and we will speculate on possible roles for NOX in the pathogenesis and development of disease. Finally, we also take into account the limited information on microglia in HD and relate this to any contribution of NOX enzymes.
format article
author Luisana Villegas
Anne Nørremølle
Kristine Freude
Frederik Vilhardt
author_facet Luisana Villegas
Anne Nørremølle
Kristine Freude
Frederik Vilhardt
author_sort Luisana Villegas
title Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
title_short Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
title_full Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
title_fullStr Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
title_full_unstemmed Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
title_sort nicotinamide adenine dinucleotide phosphate oxidases are everywhere in brain disease, but not in huntington’s disease?
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/a2319712680544fca900d3b65930a9f1
work_keys_str_mv AT luisanavillegas nicotinamideadeninedinucleotidephosphateoxidasesareeverywhereinbraindiseasebutnotinhuntingtonsdisease
AT annenørremølle nicotinamideadeninedinucleotidephosphateoxidasesareeverywhereinbraindiseasebutnotinhuntingtonsdisease
AT kristinefreude nicotinamideadeninedinucleotidephosphateoxidasesareeverywhereinbraindiseasebutnotinhuntingtonsdisease
AT frederikvilhardt nicotinamideadeninedinucleotidephosphateoxidasesareeverywhereinbraindiseasebutnotinhuntingtonsdisease
_version_ 1718444488173551616